Philippe Amouyal - Apr 28, 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role: Director
Signature: /s/ Philippe J. Amouyal
Stock symbol: LXRX
Transactions as of: Apr 28, 2023
Transactions value $: $0
Form type: 4
Date filed: 4/28/2023, 04:21 PM
Previous filing: May 23, 2022
Next filing: May 22, 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LXRX	Restricted Stock Units	Award	$0	+8.03K		$0.00	8.03K	Apr 28, 2023	Common Stock	8.03K	$0.00	Direct	F1, F2
transaction	LXRX	Stock Option (Right to Buy)	Award	$0	+12.7K		$0.00	12.7K	Apr 28, 2023	Common Stock	12.7K	$2.36	Direct	F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2	Each restricted stock unit represents a contingent right to receive one share of common stock.
F3	Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.